NPC's Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services expands upon our already strong commitment to sustainable performance built on a solid foundation of ethical behavior at all levels of business.
NPC believes that disclosing payments related to our interactions with healthcare professionals helps foster trust and supports our commitment to adhere to the highest ethical standards as outlined in the Novartis Code of Conduct.
NPC provides educational grants and charitable contributions to various organizations as a part of our mission to provide access to medicine and our commitment to helping patients and improving patient care.
The Sunshine Act was enacted by Congress in 2010 as part of the Patient Protection and Affordable Care Act, or the healthcare reform law, and is intended to provide more transparency in the relationships between the healthcare industry and physicians and teaching hospitals.
The Drug Supply Chain Security Act (DSCSA) created national requirements for tracing pharmaceutical products and includes a provision for enhanced verification, by which trading partners may request manufacturers to verify unit-level product identifiers.